Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion

Journal article

Open access

Peer reviewed

Nicole M. Ehrhardt, Vanita R. Aroda, Rodolfo J. Galindo, Anne L. Peters and Jay H. Shubrook

Clinical diabetes

2023-12-05

Files and links (1)

url

https://doi.org/10.2337/cd23-0047View

Published (Version of record) Open

1 Record Views

Title: Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion
Creators: Nicole M. Ehrhardt - University of Washington
Vanita R. Aroda - Brigham and Women's Hospital
Rodolfo J. Galindo - University of Miami Health System
Anne L. Peters - University of Southern California
Jay H. Shubrook - Touro University California
Publication Details: Clinical diabetes
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031978502602976